Aravind Reddy Tarugu

Senior Research Specalist (Biological sciences)

USA

Dr. Aravind Reddy Tarugu is a lung biologist conducting in-depth research in the pathology and pathobiology of pulmonary diseases. Dr. Tarugu significantly contributed to the lung biology field, and his discoveries helped understand the molecular mechanisms in lung diseases and develop new treatment approaches. In addition to his immense achievements and contributions, Dr. Tarugu served as an academic mentor and trained and supervised other junior members, the next generation of young researchers.

Publications

Epigallocatechin Gallate (EGCG) – A Novel Covalent NF- κB Inhibitor: Structural and Molecular Characterization
Epigallocatechin gallate suppresses inflammation in human coronary artery endothelial cells by inhibiting NF-kappaB
Glucocorticoid Receptor alpha Mediates Roflumilast's Ability to Restore Dexamethasone Sensitivity in COPD
Cigarette smoke downregulates Nur77 to exacerbate inflammation in chronic obstructive pulmonary disease (COPD)
Epigallocatechin gallate diminishes cigarette smoke-induced oxidative stress, lipid peroxidation, and inflammation in human bronchial epithelial cells
The tea catechin epigallocatechin gallate inhibits NF-kappaB-mediated transcriptional activation by covalent modification
Bidirectional interaction of airway epithelial remodeling and inflammation in asthma
Molecular, chemical, and structural characterization of prostaglandin A2 as a novel agonist for Nur77
Key Functions and Therapeutic Prospects of Nur77 in Inflammation Related Lung Diseases
Identification and Molecular Characterization of Peroxisome Proliferator-Activated Receptor delta as a Novel Target for Covalent Modification by 15-Deoxy-Delta(12,14)-prostaglandin J(2)
Role of GPx3 in PPARgamma-induced protection against COPD-associated oxidative stress
Airway Epithelial Cell Peroxisome Proliferator-Activated Receptor gamma Regulates Inflammation and Mucin Expression in Allergic Airway Disease
PPARs: Key Regulators of Airway Inflammation and Potential Therapeutic Targets in Asthma
Transforming growth factor beta suppresses peroxisome proliferator-activated receptor gamma expression via both SMAD binding and novel TGF-beta inhibitory elements
Emerging pharmaceutical therapies for COPD
PPAR Agonists for the Prevention and Treatment of Lung Cancer
PPARgamma as a Novel Therapeutic Target in Lung Cancer
PPARgamma in Bacterial Infections: A Friend or Foe?
Nitrated Fatty Acids Reverse Cigarette Smoke-Induced Alveolar Macrophage Activation and Inhibit Protease Activity via Electrophilic S-Alkylation
Nitrated fatty acids reverse pulmonary fibrosis by dedifferentiating myofibroblasts and promoting collagen uptake by alveolar macrophages
The nitrated fatty acid 10-nitro-oleate attenuates allergic airway disease
Pulmonary administration of a water-soluble curcumin complex reduces severity of acute lung injury
The Nitrated Fatty Acid 10-Nitro-oleate Diminishes Severity of LPS-Induced Acute Lung Injury in Mice
Murine model of allergen induced asthma
Endothelial cell peroxisome proliferator-activated receptor gamma reduces endotoxemic pulmonary inflammation and injury
Effects of JAM-A deficiency or blocking antibodies on neutrophil migration and lung injury in a murine model of ALI
Role of GPx3 in PPAR$γ$-induced protection against COPD-associated oxidative stress
Cigarette Smoke Downregulates Nur77 to Exacerbate Airway Inflammation in Chronic Obstructive Pulmonary Disease (COPD)
Epigallocatechin gallate suppresses inflammation in human coronary artery endothelial cells by inhibiting NF-$κ$B
Glucocorticoid receptor $α$ mediates roflumilast’s ability to restore dexamethasone sensitivity in COPD
Airway epithelial cell peroxisome proliferator--activated receptor $γ$ regulates inflammation and mucin expression in allergic airway disease
Identification and Molecular Characterization of Peroxisome Proliferator-Activated Receptor $δ$ as a Novel Target for Covalent Modification by 15-Deoxy-$Δ$12, 14-prostaglandin J2
Peroxisome Proliferator-Activated Receptor $γ$-Mediated Regulation of Glutathione Peroxidase 3 in COPD
The tea catechin epigallocatechin gallate inhibits NF-$κ$B-mediated transcriptional activation by covalent modification
Prostaglandin A2-Mediated Activation of the Nuclear Receptor Nur77 in Lung Diseases
C75 FIBROSIS: CURRENT AND FUTURE APPROACHES: Transforming Growth Factor $β$ Suppresses Peroxisome Proliferator-activated Receptor $γ$ Expression Via Both Smad Binding And Novel Tgf-$β$ Inhibitory Elements
Essential need for rethink of COPD airway pathology: implications for new drug approaches for prevention of lung cancer as well as small airway fibrosis
Essential need for rethink of COPD airway pathology: implications for new drug approaches for prevention of lung cancer as well as small airway fibrosis Reply
On this page
Transforming Growth Factor $β$ Suppresses Peroxisome Proliferator--Activated Receptor $γ$ Expression Via Both SMAD Binding And Novel TGF-$β$ Inhibitory Elements
Transforming growth factor $β$ suppresses peroxisome proliferator-activated receptor $γ$ expression via both SMAD binding and novel TGF-$β$ inhibitory elements
Transforming Growth Factor beta Suppresses Peroxisome Proliferator-activated Receptor. Expression Via Both Smad Binding And Novel Tgf-beta Inhibitory Elements
PPAR agonists for the prevention and treatment of lung cancer
PPARs: key regulators of airway inflammation and potential therapeutic targets in asthma
Key functions and therapeutic prospects of Nur77 in inflammation related lung diseases
D36 SEPSIS, ACUTE RESPIRATORY DISTRESS SYNDROME, AND ACUTE LUNG INJURY: Induction Of F-Box Proteins By LPS Stimulation In A Human Monocytic Cell Line: Implications In Acute Lung Injury
C30 LATE BREAKING ABSTRACTS IN DISEASE TREATMENT AND CLINICAL OUTCOMES: Roflumilast-Glucocorticoid Synergy In COPD
Cysteine S-Alkylation Of Proteases As Potential Therapeutic Mechanism For COPD
B110 COPD GALORE: NEW INSIGHTS INTO BRONCHITIS AND EMPHYSEMA DEVELOPMENT AND TREATMENT: Cysteine S-Alkylation Of Proteases As Potential Therapeutic Mechanism For COPD
PPAR𝛾 in Bacterial Infections: A Friend or Foe?
PPAR𝛾 as a Novel Therapeutic Target in Lung Cancer
Nitrated fatty acids reverse cigarette smoke-induced alveolar macrophage activation and inhibit protease activity via electrophilic S-alkylation
Airway Epithelial Cell Peroxisome Proliferator-Activated Receptor $γ$ (PPAR$γ$) Is A Crucial Regulator Of Allergic Airway Disease
Epigallocatechin gallate suppresses inflammation in human coronary artery endothelial cells by inhibiting NF-kappa B
C22 AIRWAY EPITHELIUM: MOLECULAR REGULATION OF INFLAMMATION: Airway Epithelial Cell Peroxisome Proliferator-Activated Receptor [gamma](ppar [gamma]) Is A Crucial Regulator Of Allergic Airway Disease
The nitrated fatty acid 10-nitro-oleate diminishes severity of LPS-induced acute lung injury in mice
Endothelial Cell Peroxisome Proliferator-Activated Receptor-Gamma Protects Against Sepsis-Induced Acute Lung Injury
Endothelial Cell Peroxisome Proliferator-Activated Receptor gamma Reduces Endotoxemic Pulmonary Inflammation and Injury
Endothelial cell peroxisome proliferator--activated receptor $γ$ reduces endotoxemic pulmonary inflammation and injury
The Nitrated Fatty Acid 10-Nitro-Oleate
Suppressing Allergic Airway Disease with Nitrated Fatty Acids
Nitrated Fatty Acids Inhibit Allergic Airway Disease
Roflumilast-glucocorticoid synergy in COPD
Induction Of F-Box Proteins By LPS Stimulation In A Human Monocytic Cell Line: Implications In Acute Lung Injury
D41 COPD: BIOMARKERS IN STABLE DISEASE AND EXACERBATIONS: Crucial Role Of Ppar [gamma] Downregulation And Activation In COPD
The tea catechin epigallocatechin gallate inhibits NF-kappa B-mediated transcriptional activation by covalent modification
Molecular, chemical, and structural characterization of prostaglandin A(2) as a novel agonist for Nur77

Aravind Reddy Tarugu

Publications

Usage metrics

Aravind Reddy Tarugu's public data